Allogeneic versus autologous stem cell transplantation after relapsing following first line autologous transplantation for multiple myeloma: A systematic review.

Saved in:
Bibliographic Details
Title: Allogeneic versus autologous stem cell transplantation after relapsing following first line autologous transplantation for multiple myeloma: A systematic review.
Authors: Ludwig H; Wilhelminen Cancer Research Institute, Vienna, Austria., Bernhard S; Wilhelminen Cancer Research Institute, Vienna, Austria., Ikeda T; Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, Japan., Freytes CO; University of Texas Health Science Center San Antonio, San Antonio, Texas, USA., Schreder M; Department of Medicine I, Center for Oncology and Hematology, Clinic Ottakring, Vienna, Austria., Kawamura K; Hematology, Tottori University Hospital, Yonago, Japan., Atsuta Y; Japanese Data Center For Hematopoietic Cell Transplantation, Nagakute, Japan., Takamatsu H; Kanazawa University, Kanazawa, Ishikawa, Japan., Vesole DH; Myeloma Division, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack, New Jersey, USA., Hari P; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Krainer J; Wilhelminen Cancer Research Institute, Vienna, Austria., Hinke A; Cancer Clinical Research Consulting, Düsseldorf, Germany.
Source: Cancer [Cancer] 2025 May 15; Vol. 131 (10), pp. e35896.
Publication Type: Journal Article; Systematic Review; Comparative Study; Meta-Analysis
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1097-0142
DOI:10.1002/cncr.35896